Volpara Health Technologies Ltd VHT
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if VHT is a good fit for your portfolio.
News
-
Volpara Health Appoints Clarity Quest as Agency of Record
-
Volpara Launches MQSA Compliance Software at the Society for Breast Imaging Symposium
-
Volpara to Showcase AI Software for Breast Centers at NCBC 2024, Including Lunit INSIGHT for Early Detection
-
Update on Lunit's Acquisition of Volpara: New Zealand High Court Initial Approval Secured
Trading Information
- Previous Close Price
- A$1.14
- Day Range
- A$1.14–1.15
- 52-Week Range
- A$0.63–1.15
- Bid/Ask
- A$0.00 / A$0.00
- Market Cap
- A$291.26 Mil
- Volume/Avg
- 1.3 Mil / 615,461
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 8.30
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Volpara Health Technologies Ltd is a New Zealand-based research, development, and manufacturing company. The business of the company operates through three product categories that include Capital Sales, Software Maintenance Agreements, and Software as a Service. It offers a breast imaging analytics platform that delivers real-time quality assurance and performance monitoring. It operates through the sale of a single suite of medical device software products.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Small Growth
- Total Number of Employees
- 175
- Website
- https://www.volparahealth.com
Comparables
Valuation
Metric
|
VHT
|
IFM
|
AVDX
|
---|---|---|---|
Price/Earnings (Normalized) | — | 28.33 | 63.83 |
Price/Book Value | 6.52 | 4.36 | 3.49 |
Price/Sales | 8.30 | 4.37 | 5.75 |
Price/Cash Flow | 104.80 | 13.19 | 46.95 |
Price/Earnings
VHT
IFM
AVDX
Financial Strength
Metric
|
VHT
|
IFM
|
AVDX
|
---|---|---|---|
Quick Ratio | 0.59 | 3.50 | 0.39 |
Current Ratio | 0.88 | 3.77 | 1.34 |
Interest Coverage | −48.87 | — | −2.99 |
Quick Ratio
VHT
IFM
AVDX
Profitability
Metric
|
VHT
|
IFM
|
AVDX
|
---|---|---|---|
Return on Assets (Normalized) | −8.77% | 9.78% | 0.57% |
Return on Equity (Normalized) | −13.89% | 12.73% | 1.89% |
Return on Invested Capital (Normalized) | −13.49% | 11.17% | 0.81% |
Return on Assets
VHT
IFM
AVDX
Health Information Services Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
GEHC
| GE HealthCare Technologies Inc Common Stock | — | Cvbcbz | $36.8 Bil | |
VEEV
| Veeva Systems Inc Class A | Psfplqpxqm | Tzw | $34.2 Bil | |
SOLV
| Solventum Corp | — | Wqnnbg | $11.2 Bil | |
PMCUF
| Pro Medicus Ltd | — | Njdvhdx | $7.8 Bil | |
MTHRF
| M3 Inc | — | Xzjrmf | $7.3 Bil | |
MTHRY
| M3 Inc ADR | — | Fwzgpy | $7.3 Bil | |
HQY
| HealthEquity Inc | — | Kzzkmgk | $6.6 Bil | |
RCM
| R1 RCM Inc | — | Ddfd | $5.1 Bil | |
DOCS
| Doximity Inc Class A | — | Jxzbxk | $4.4 Bil | |
TXG
| 10x Genomics Inc Ordinary Shares - Class A | — | Bktx | $3.2 Bil |